ZYME insider transactions

SEC Form 4 filed by EVP, General Counsel Schneider Paul R

New insider Schneider Paul R claimed no ownership of stock in the company (SEC Form 3)

SEC Form 4 filed by Schayowitz Adam

SEC Form 4 filed by Platshon Scott

SEC Form 3 filed by new insider Platshon Scott

SEC Form 3 filed by new insider Schayowitz Adam

SEC Form 4 filed by Stafford Kristin

SEC Form 3 filed by new insider Stafford Kristin

New insider Mekan Sabeen claimed no ownership of stock in the company (SEC Form 3)

EVP & Chief Operating Officer Hollywood Mark converted options into 17,666 shares and sold $138,762 worth of shares (6,120 units at $22.67), increasing direct ownership by 10% to 132,913 units (SEC Form 4)

New insider Hollywood Mark claimed ownership of 121,367 shares (SEC Form 3)

SEC Form 4 filed by Director Cherry Brian N

New insider Cherry Brian N claimed no ownership of stock in the company (SEC Form 3)

EVP & Chief Medical Officer Smith Jeffrey T L sold $211,090 worth of shares (9,310 units at $22.67) and converted options into 17,666 shares, increasing direct ownership by 46% to 26,708 units (SEC Form 4)

SEC Form 4 filed by Director Ciongoli Gregory Austin

SEC Form 4 filed by Director Neu Kelvin

SEC Form 4 filed by Director Landry Robert E

SEC Form 4 filed by Director Cesano Alessandra

SEC Form 4 filed by Director Campoy Carlos

SEC Form 4 filed by Director Mahony Susan

Chief Scientific Officer Moore Paul Andrew converted options into 17,666 shares and sold $216,759 worth of shares (9,560 units at $22.67), increasing direct ownership by 20% to 48,497 units (SEC Form 4)

Chair & CEO Galbraith Kenneth converted options into 64,000 shares and sold $689,819 worth of shares (30,424 units at $22.67), increasing direct ownership by 17% to 226,842 units (SEC Form 4)

EVP, Chief Bus & Fin Officer Patterson Leone D was granted 459 shares (SEC Form 4)

EVP & Chief Medical Officer Smith Jeffrey T L sold $264,471 worth of shares (10,538 units at $25.10) and converted options into 20,000 shares, increasing direct ownership by 106% to 18,352 units (SEC Form 4)

Chair & CEO Galbraith Kenneth converted options into 114,334 shares and sold $1,363,841 worth of shares (54,343 units at $25.10), increasing direct ownership by 45% to 193,266 units (SEC Form 4)

Chief Scientific Officer Moore Paul Andrew converted options into 37,168 shares and sold $504,699 worth of shares (20,110 units at $25.10), increasing direct ownership by 73% to 40,391 units (SEC Form 4)

Chair & CEO Galbraith Kenneth converted options into 100,000 shares and sold $1,284,311 worth of shares (47,528 units at $27.02), increasing direct ownership by 65% to 133,275 units (SEC Form 4)

Director Ciongoli Gregory Austin was granted 415,000 shares, increasing direct ownership by 565% to 488,500 units (SEC Form 4)

SEC Form 4 filed by Director Landry Robert E

New insider Landry Robert E claimed no ownership of stock in the company (SEC Form 3)

New insider Ciongoli Gregory Austin claimed ownership of 78,500 shares (SEC Form 3)

Director Ecor1 Capital, Llc exercised 5,086,480 in-the-money shares at a strike of $0.00 and covered exercise/tax liability with 41 shares (SEC Form 4)

Director Ecor1 Capital, Llc bought $635,586 worth of shares (55,421 units at $11.47) (SEC Form 4)

Director Ecor1 Capital, Llc bought $1,456,408 worth of shares (128,713 units at $11.32) (SEC Form 4)

Director Ecor1 Capital, Llc bought $3,623,970 worth of shares (317,208 units at $11.42) (SEC Form 4)

Director Ecor1 Capital, Llc bought $1,497,322 worth of shares (127,415 units at $11.75) (SEC Form 4)

Director Ecor1 Capital, Llc bought $1,227,309 worth of shares (97,349 units at $12.61) (SEC Form 4)

Director Ecor1 Capital, Llc bought $1,643,248 worth of shares (127,198 units at $12.92) (SEC Form 4)

Director Ecor1 Capital, Llc bought $2,866,553 worth of shares (228,463 units at $12.55) (SEC Form 4)

Director Ecor1 Capital, Llc bought $13,120,914 worth of shares (1,081,980 units at $12.13) (SEC Form 4)

New insider Nodelman Oleg claimed ownership of 15,720,161 shares (SEC Form 3)

Director Ecor1 Capital, Llc bought $1,963,538 worth of shares (141,429 units at $13.88) (SEC Form 4)

Director Ecor1 Capital, Llc bought $2,278,811 worth of shares (167,654 units at $13.59) (SEC Form 4)

Director Ecor1 Capital, Llc bought $2,974,819 worth of shares (225,119 units at $13.21) (SEC Form 4)

SEC Form 4 filed by EVP, Chief Bus & Fin Officer Patterson Leone D

SEC Form 4 filed by Chief Scientific Officer Moore Paul Andrew

SEC Form 4 filed by EVP & Chief Medical Officer Smith Jeffrey T L

SEC Form 4 filed by Chair & CEO Galbraith Kenneth

Chief Scientific Officer Moore Paul Andrew converted options into 37,166 shares and sold $316,391 worth of shares (21,200 units at $14.92), increasing direct ownership by 217% to 23,333 units (SEC Form 4)

Chair & CEO Galbraith Kenneth converted options into 114,332 shares and sold $855,017 worth of shares (57,291 units at $14.92), increasing direct ownership by 240% to 80,803 units (SEC Form 4)

EVP & Chief Medical Officer Smith Jeffrey T L converted options into 20,000 shares and sold $165,807 worth of shares (11,110 units at $14.92) (SEC Form 4)

Director Ecor1 Capital, Llc bought $5,321,176 worth of shares (363,369 units at $14.64) (SEC Form 4)

Director Ecor1 Capital, Llc bought $1,882,115 worth of shares (130,309 units at $14.44) (SEC Form 4)

Amendment: Director Ecor1 Capital, Llc bought $17,544,284 worth of shares (1,254,808 units at $13.98) (SEC Form 4)

SEC Form 4 filed by Large owner Ecor1 Capital, Llc

SEC Form 4 filed by Director Miller Derek John Michael

SEC Form 4 filed by Director Campoy Carlos

SEC Form 4 filed by Director Cesano Alessandra

SEC Form 4 filed by Director Neu Kelvin

SEC Form 4 filed by Director Davidson Nancy